X4 Pharmaceuticals, Inc reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
X4 Pharmaceuticals, Inc has filed 796 SEC EDGAR filings since 24 Sep 2010

SEC filing history

Showing 26-50 of 796 matching filings.

Per page
25
Current page
2
4

FORM 4

Filing date
05 Jan 2026
Reporting date
01 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Jan 2026
Reporting date
01 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Jan 2026
Reporting date
01 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-90199

SCHEDULE 13G filing

Filing date
14 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-90199

SCHEDULE 13G filing

Filing date
07 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-90199

SCHEDULE 13G filing

Filing date
03 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
31 Oct 2025
Reporting date
29 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
31 Oct 2025
Reporting date
29 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
31 Oct 2025
Reporting date
29 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-90199

SCHEDULE 13D/A filing

Filing date
29 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Oct 2025
Reporting date
23 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-273961

424B5

Filing date
24 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-273961

424B5

Filing date
23 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-90199

SCHEDULE 13G filing

Filing date
21 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-90199

SCHEDULE 13G filing

Filing date
03 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-290158

424B3

Filing date
18 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-290158

EFFECT filing

Filing date
17 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
15 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-90199

SCHEDULE 13G filing

Filing date
15 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-290158

UPLOAD filing

Filing date
15 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-290158

S-3

Filing date
10 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .